Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 3:22 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2089–2112 of 17,766 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control Population Clear all

Conditions: Overweight and Obesity, Pregnancy
Interventions: Intervention to reduce excess weight gain during pregnancy; Behavioral
Lead sponsor: Tufts University; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Anxiety
Interventions: Guided Drawing Intervention, Free Drawing Control, Basic Control; Behavioral
Lead sponsor: Penn State University; Other
Eligibility: 13 Years to 25 Years
Enrollment: 275 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: University Park, Pennsylvania

Conditions: Mental Health, Emotional Wellbeing, Anxiety, Depression, Stress, Coping, Perceived Stress, Perceived Social Support
Interventions: COPE: Communities Organizing for Power through Empathy; Behavioral
Lead sponsor: Louisiana State University and A&M College; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Diabetes Mellitus
Interventions: InPen Smart insulin pen, traditional/standard insulin pen; Device · Other
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 2
States / cities: Baltimore, Maryland

Conditions: E-cigarette Use
Interventions: CATCH My Breath (CMB) program for E-cigarette prevention among adolescents, Texas Education Agency (TEA) required tobacco prevention program; Behavioral
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 10 Years to 15 Years
Enrollment: 2,059 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Central Abdominal Bulging
Interventions: LIPO-202, Placebo; Drug
Lead sponsor: Neothetics, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2015
U.S. locations: 6
States / cities: Encinitas, California • Manhattan Beach, California • Aventura, Florida + 3 more

Conditions: Solid Tumor, Leukemia, Lymphoma, Brain Tumor
Interventions: IMPACT, ESO; Behavioral · Other
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 0 Years to 18 Years
Enrollment: 279 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2022
U.S. locations: 3
States / cities: Cincinnati, Ohio • Dayton, Ohio • Oklahoma City, Oklahoma

Conditions: Overdose
Interventions: MI-CHANCE (TS + FTIR + MI), TS + FTIR + Flu and Hepatitis A Education; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 588 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: San Diego, California

Conditions: Pulmonary Arterial Hypertension
Interventions: Selexipag, Placebo; Drug
Lead sponsor: Actelion; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 108 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 15
States / cities: Torrance, California • Atlanta, Georgia • Louisville, Kentucky + 11 more

Conditions: Liver Metastasis Colon Cancer
Interventions: Living Donor Liver Transplantation; Procedure
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 65 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2030
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Medication Compliance
Interventions: Pharmacist-led medication therapy using mHealth application; Other
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 136 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Hypertension
Interventions: Nebivolol, Placebo; Drug
Lead sponsor: Forest Laboratories; Industry
Eligibility: 18 Years to 54 Years
Enrollment: 641 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 75
States / cities: Phoenix, Arizona • Buena Park, California • Burbank, California + 58 more

Conditions: Bronchiectasis
Interventions: Inhaled mannitol, Matched control; Drug
Lead sponsor: Syntara; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 485 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 19
States / cities: Denver, Colorado • Farmington, Connecticut • Washington D.C., District of Columbia + 15 more

Conditions: Asthma, Medical Informatics
Interventions: Paper-based asthma flow diagram; Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 2 Years to 18 Years
Enrollment: 1,102 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2015
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Diabetes Mellitus, Type 2
Interventions: albiglutide, sitagliptin; Biological · Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years and older
Enrollment: 507 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 121
States / cities: Birmingham, Alabama • Gulf Shores, Alabama • Huntsville, Alabama + 97 more

Conditions: Cardiovascular Primary Prevention Strategy
Interventions: Coronary Artery Calcium Screening and Statin Treatment, Standard Treatment; Combination Product · Other
Lead sponsor: Intermountain Health Care, Inc.; Other
Eligibility: 50 Years to 80 Years
Enrollment: 5,765 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2027
U.S. locations: 1
States / cities: Murray, Utah

Conditions: Wounds and Injuries, Venous Thromboembolism
Interventions: Aspirin and Rosuvastatin, Placebo (for Aspirin and Rosuvastatin); Drug
Lead sponsor: Denver Health and Hospital Authority; Other
Eligibility: 18 Years to 65 Years
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Diabetes
Interventions: Accu-Chek 360 software, Normal care; Other
Lead sponsor: Columbus Research Foundation; Other
Eligibility: 19 Years to 65 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Columbus, Georgia

Conditions: Cognitive Aging, Alzheimer Disease, Protection Against
Interventions: Active NIR-PBM, Sham NIR-PBM; Device
Lead sponsor: University of Florida; Other
Eligibility: 65 Years to 89 Years
Enrollment: 168 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2026
U.S. locations: 2
States / cities: Tucson, Arizona • Gainesville, Florida

Conditions: Pulmonary Sarcoidosis
Interventions: nicotine patch; Drug
Lead sponsor: Elliott Crouser MD; Other
Eligibility: 18 Years and older
Enrollment: 64 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Type 2 Diabetes Mellitus
Interventions: KD026, Placebo, Metformin; Drug
Lead sponsor: Response Pharmaceuticals; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 121 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 10
States / cities: Birmingham, Alabama • Los Angeles, California • West Hills, California + 6 more

Conditions: Diabetes Mellitus, Type 2, Renal Insufficiency
Interventions: BI 10773, Placebo; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 18 Years and older
Enrollment: 741 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 18
States / cities: Anaheim, California • Lomita, California • Plantation, Florida + 15 more

Conditions: Transfemoral Amputation
Interventions: MIT Powered Leg; Device
Lead sponsor: Massachusetts Institute of Technology; Other
Eligibility: 18 Years to 70 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Conditions: Post Traumatic Stress Disorder, Major Depressive Disorder
Interventions: Mindfulness-Based Cognitive Therapy; Behavioral
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Atlanta, Georgia

Search by objective public record fields.

Interventions to Reduce Excess Weight Gain in Pregnancy

Drawing and Anxiety Study

Strengthening Community Mental Health

Improving Glycemic Control With Telemedicine and Smart Insulin Pens

Middle School Cluster Randomized Controlled Trial (RCT) to Evaluate E-Cigarette Prevention Program: CATCH My Breath

Safety and Efficacy Study of LIPO-202 for the Reduction of Central Abdominal Bulging in Obese Subjects

Illness Management and Parental Adjustment to Cancer Treatment

Motivational Interviewing to Increase Uptake of Drug Checking and Safe Drug Use Behaviors to Reduce Overdose

Effect of Selexipag on Daily Life Physical Activity of Patients With Pulmonary Arterial Hypertension.

Living Donor Liver Transplantation for CRC Liver Metastases

mHealth Medication Safety Intervention

Study of the Efficacy and Safety of Nebivolol in Younger Patients (18 - 54 Years)

Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis

A Reminder System for Paper-Based Asthma Guidelines in the Pediatric Emergency Department

A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment.

Effectiveness of a Proactive Cardiovascular Primary Prevention Strategy, With or Without the Use of Coronary Calcium Screening, in Preventing Future Major Adverse Cardiac Events

STAT-STatin and Aspirin in Trauma

Remote Management of Diabetic Patients Via Data Transmission by Accu-Chek 360 Software

The Revitalize Study in Older Adults at Risk for Alzheimer's Disease

Study of Nicotine Patches in Patients With Sarcoidosis

Study of KD026 in Combination With Metformin in Subjects With Type 2 Diabetes Mellitus

Efficacy and Safety of Empagliflozin (BI 10773) in Patients With Type 2 Diabetes and Renal Impairment

Evaluation of a Neural-Controlled Powered Prosthesis Across Diverse Real-World Tasks

Primary-Care Based Mindfulness Intervention